Our Artificial Intelligence solutions provide superior diagnostic and therapeutic care for millions of individuals at risk of experiencing retinal diseases - a leading cause of severe vision loss and blindness.
RetInSight is tracked in the Tech.eu funding database. Based in Vienna, Austria; active in Healthtech. Acquired by Topcon Healthcare in 2025. Data as of 25 Oct 2026.
Global coverage: FundingData
